The company expects that this development could improve the strength of its application to the FDA for new drug approval
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
Three-point improvement achieved in Sex Ratio at Birth from 904 in 2017-19 to 907 in 2018-20
Short-term treatment of heartburn and other symptoms associated with gastroesophageal reflux disease (GERD)
Merck to pay Daiichi Sankyo a $4 billion upfront payment in addition to $1.5 billion in continuation payments over the next 24 months
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
The plant has a capacity for extraction of 2500 mt of poppy straw and 300 mt poppy gum per year
Seamless transition from preclinical to first-in-human trials with EUDRACAP platform technology
Glenmark's current portfolio consists of 188 products authorized for distribution in the US
Subscribe To Our Newsletter & Stay Updated
